STAGE IV PENILE CANCER AJCC V8
Clinical trials for STAGE IV PENILE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PENILE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV PENILE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail targets rare cancers that have spread
Disease control Recruiting nowThis study is testing a combination of three drugs (cabozantinib, nivolumab, and ipilimumab) in people with rare cancers of the urinary and reproductive systems that have spread to other parts of the body. The goal is to see if this mix can shrink tumors better than any single dr…
Matched conditions: STAGE IV PENILE CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New drug shows promise for rare penile cancer
Disease control Recruiting nowThis study tests a drug called enfortumab vedotin for people with penile cancer that has spread or cannot be removed by surgery. The drug targets a protein on cancer cells to deliver a toxin that kills them. About 28 adults will take part to see if the drug can shrink tumors and …
Matched conditions: STAGE IV PENILE CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 13, 2026 15:59 UTC